Term
|
Definition
| water soluble and not absorbed because of large molecular size. After IV it stays in plasma to increase plasma volume. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| reacts in the bladder with ACROLEINE a metabolite of anticancer drug, preventing hemorrhagic cystitis |
|
|
Term
|
Definition
| increases the osmolarity of various body fluids. Promotes diuresis, catharsis, expansion of circulating volume in the vascular compartment or reduction of cerebral edema. |
|
|
Term
|
Definition
| Binds bile acids in the intestinal lumen and prevents reabsorption. Used for hyperlipidemia |
|
|
Term
|
Definition
|
|
Term
| structural analogs of pyrimidines and purines |
|
Definition
| incorporated into NA and alter function. Anticancer and antiviral chemotherapy. |
|
|
Term
| Antacid, mesma, mannitol, cholestyramine, dimercaprol, pyrimidines, purine analogs |
|
Definition
| Exceptions of drugs not mediated by receptors. |
|
|
Term
|
Definition
irreversible competitive antagonist. alpha adrenoceptor blocker used for pheochromocytoma |
|
|
Term
| aspririn, omeprazole, MAO inhibitors |
|
Definition
| irreversible competitive antagonists |
|
|
Term
|
Definition
| a dissociative anethetic, non competitive antagonist at the NMDA receptor |
|
|
Term
|
Definition
Both uncompetitive antagonists Memantine- antag against NMDA receptor in Alzheimers. Lithium- inhibitor of inositol monophosphatase, used in bipolar disorder. |
|
|
Term
|
Definition
Chemical antagonist protein that is positively charged and counteracts the effects of heparin- anticoagulant that is negatively charged. |
|
|
